Metformin is effective in improving rosacea-like lesions, reducing LL-37- and TNF-α-induced reactive oxygen production, and mitigating mitogen-activated protein kinase/NF-κB signal activation in keratinocytes (176). This evidence concerns the gene NFKB1 and rosacea.